Health Insurance (Epicutaneous patch testing) Determination 2016 (Cth)

Health Insurance (Epicutaneous patch testing) Determination 2016

I, MICHAEL RYAN, delegate of the Minister for Health and Aged Care, make this Determination under subsection 3C(1) of the Health Insurance Act 1973. 

Dated    20^th December 2016

Michael Ryan

A/g Assistant Secretary

Medical Specialist Services Branch

Medical Benefits Division

Department of Health

Contents

1.           Name of Determination

2.           Commencement

3.           Authority

4.           Definitions

5.           Treatment of relevant services

6.           Effect of specified provisions

Schedule – relevant services

1. Name of Determination

This Determination is the Health Insurance (Epicutaneous patch testing) Determination 2016.

1. Commencement

This Determination is taken to have commenced on 1 November 2016.

1. Authority

This Determination is made under subsection 3C(1) of the Health Insurance Act 1973.

1. Definitions

1. In this Determination:

Act means the Health Insurance Act 1973.

relevant provisions means all provisions, of the Act and regulations made under the Act, and the National Health Act 1953 and regulations made under that Act, relating to medical services, professional services or items.

relevant service means a health service, as defined in subsection 3C(8) of the Act, that is specified in the Schedule.

Schedule means the Schedule to this Determination.

Note:       The following terms are defined in subsection 3(1) of the Act:

·clinically relevant

·general medical services table

·item

·professional service

(2)    Unless the contrary intention appears, a reference in this Determination to a provision of the Act or the National Health Act 1953 or regulations made under the Act or under the National Health Act 1953 as applied, adopted or incorporated in relation to specifying a matter is a reference to those provisions as in force from time to time and any other reference to provisions of an Act or regulations is a reference to those provisions as in force from time to time.

1. Treatment of relevant services

For subsection 3C(1) of the Act:

(a)          a relevant service, provided in accordance with this Determination and as a clinically relevant service, is to be treated, for the relevant provisions, as if:

(i)it were both a professional service and a medical service; and

(ii)there were an item in the general medical services table that:

(A)related to the service; and

(B)specified for the service a fee in relation to each State, being the fee specified in the Schedule in relation to the service.

1. Effect of specified provisions

(1)     Subclause 1.2.8(1) of the general medical services table shall have effect as if it included a reference to items 12025, 12026 and 12027.

(2)     Items 12000 and 12003 of the general medical services table shall have effect as if the reference to items 12012, 12017, 12021, 12022 or 12024 included a reference to items 12025, 12026 and 12027.

Schedule – relevant services

Group D1—Miscellaneous diagnostic procedures and investigations
Item	Service	Fee ($)
Subgroup 9—Allergy testing
12025	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a consultant physician in the practice of his or her specialty, using more than 50 allergens but not more than 75 allergens	115.50
12026	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a consultant physician in the practice of his or her specialty, using more than 75 allergens but not more than 100 allergens	135.65
12027	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a consultant physician in the practice of his or her specialty, using more than 100 allergens	154.50